×
| Stock | Total Income | Net Profit | Net Sales | EPS | Market Cap (in Cr) | P/E |
|---|---|---|---|---|---|---|
| SOUTHERN GAS LTD. | NA | NA | NA | NA | 0.06 | 0.03 |
| INDO GULF INDUSTRIES LTD. | NA | NA | NA | NA | 0 | |
| Epigral Limited | 6147.9 | 1604.1 | 6065.4 | 37.18 | 7,609 | 17.6 |
| GUJARAT NARMADA VALLEY FERTILI | 17510.0 | 780.0 | 16010.0 | 5.31 | 7419 | 13.2 |
| FISCHER MEDICAL VENTURES LIMIT | 53.46 | -6.09 | 45.42 | -0.09 | 7361 | 1,114 |
Epigral Limited, with Security Code 543332, is a leading player in the Specialty Chemicals industry, categorized under the Commodities sector, offering Equity instruments.
| Metrics | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 537.8 | 562.2 | 454.9 | 478.1 | 471.5 | 524.6 | 651.2 | 626.1 | 645.2 | 606.5 |
| Expenses | 371.3 | 407.5 | 359.7 | 370.3 | 348.8 | 369.2 | 474.8 | 447.6 | 462.6 | 443.2 |
| Operating Profit | 166.5 | 154.7 | 95.2 | 107.9 | 122.8 | 155.4 | 176.4 | 178.4 | 182.7 | 163.4 |
| OPM % | 30.96% | 27.52% | 20.93% | 22.56% | 26.04% | 29.62% | 27.09% | 28.5% | 28.31% | 26.94% |
| Other Income | -0.3 | 4.5 | 1.5 | 1.0 | 2.5 | 1.5 | 2.4 | 5.6 | 3.9 | 8.3 |
| Interest | 21.0 | 19.0 | 18.3 | 21.3 | 20.2 | 13.7 | 14.3 | 27.3 | 0.1 | 23.4 |
| Depreciation | 30.8 | 30.1 | 30.8 | 31.5 | 30.9 | 30.4 | 33.5 | 32.3 | 32.9 | 41.5 |
| Profit before tax | 114.4 | 110.1 | 47.6 | 56.1 | 74.2 | 112.9 | 131.1 | 124.4 | 153.5 | 106.7 |
| Tax % | -32.5% | -30.3% | -33.4% | -32% | -33.5% | -32.1% | -34.4% | -35.3% | -32.6% | -50.3% |
| Net Profit | 77.2 | 76.8 | 31.7 | 38.1 | 49.3 | 76.7 | 86.0 | 80.5 | 103.5 | 160.4 |
| EPS in Rs | 18.58 | 18.48 | 7.62 | 9.18 | 11.87 | 18.45 | 20.7 | 19.38 | 24.23 | 37.18 |
| Metrics | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 537.8 | 562.2 | 454.9 | 478.1 | 471.5 | 524.6 | 651.2 | 626.1 | 645.2 | 627.6 |
| Expenses | 371.3 | 407.5 | 359.9 | 370.4 | 349.0 | 369.2 | 474.8 | 447.6 | 462.6 | 454.2 |
| Operating Profit | 166.5 | 154.6 | 95.0 | 107.7 | 122.5 | 155.4 | 176.4 | 178.4 | 182.7 | 173.5 |
| OPM % | 30.96% | 27.51% | 20.89% | 22.53% | 25.99% | 29.62% | 27.09% | 28.5% | 28.31% | 27.64% |
| Other Income | -0.3 | 4.5 | 1.5 | 1.0 | 2.5 | 1.5 | 2.4 | 5.6 | 3.9 | 3.4 |
| Interest | 21.0 | 19.0 | 18.3 | 21.3 | 20.2 | 13.7 | 14.3 | 27.3 | 0.1 | 11.8 |
| Depreciation | 30.8 | 30.1 | 30.8 | 31.5 | 30.9 | 30.4 | 33.5 | 32.3 | 32.9 | 34.0 |
| Profit before tax | 114.4 | 110.1 | 47.4 | 55.9 | 73.9 | 112.9 | 131.1 | 124.4 | 153.5 | 131.1 |
| Tax % | -32.5% | -30.3% | -33.4% | -32% | -33.5% | -32.1% | 34.4% | 35.3% | 32.6% | -33.9% |
| Net Profit | 77.2 | 76.7 | 31.5 | 38.0 | 49.1 | 77.3 | 85.9 | 81.3 | 103.6 | 86.9 |
| EPS in Rs | 18.58 | 18.47 | 7.58 | 9.14 | 11.81 | 18.6 | 20.67 | 19.57 | 24.25 | 0 |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 33% |
| 3 Years: | 18% |
| TTM: | 32% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 26% |
| 3 Years: | 12% |
| TTM: | 82% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 12% |
| 1 Year: | 44% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 18% |
| TTM: | 32% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 12% |
| TTM: | 83% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 12% |
| 1 Year: | 44% |
Recent Bets
|
Date
|
Stock
|
Party
|
Deal
|
Acq. Mode
|
Trans.
|
Quan.
|
Price
|
Value
|
|---|
| Period | SMA Value | Status |
|---|
| Period | EMA Value | Status |
|---|
| Indicator | Value |
|---|